Nucleotide substitution: G?A.
Base change GAG->AAG.
Fmr1E68K.EP3517 carries both the P{EP} insertion present in the progenitor allele and the amino acid replacement in the Fmr1 coding region.
Amino acid replacement: E68K.
G10106013A
G?A
E68K | Fmr1-PA; E68K | Fmr1-PB; E68K | Fmr1-PC; E68K | Fmr1-PD; E30K | Fmr1-PE; E30K | Fmr1-PF; E116K | Fmr1-PG; E116K | Fmr1-PH; E30K | Fmr1-PI; E68K | Fmr1-PJ; E68K | Fmr1-PK
E68K
Transheterozygosity to Fmr1Δ113M, or overexpression by Scer\GAL4P2.4.Pdf, result in a defasciculation phenotype of the termini of the LNv neuron's dorsal projections.
Fmr1E68K.EP3517, Scer\GAL4P2.4.Pdf has abnormal neuroanatomy phenotype, non-suppressible by CyfipUAS.cSa, Scer\GAL4P2.4.Pdf
CyfipUAS.cSa, Fmr1E68K.EP3517, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype
Fmr1E68K.EP3517, Scer\GAL4P2.4.Pdf has LNv neuron phenotype, non-suppressible by CyfipUAS.cSa, Scer\GAL4P2.4.Pdf
CyfipUAS.cSa, Fmr1E68K.EP3517, Scer\GAL4elav.PU has neuromuscular junction phenotype
Co-expression of Sra-1Scer\UAS.cSa does not suppress the defasciculation of LNv neurons caused by Scer\GAL4P2.4.Pdf; Fmr1E68K.EP3517
Co-overexpression of Fmr1E68K.EP3517 and Sra-1Scer\UAS.cSa using Scer\GAL4elav.PU results in a significant neuromuscular junction overgrowth phenotype.
Selected as: A mutation that suppresses the lethality caused when a Scer\GAL4 driver is used to overexpress Fmr1 from the P{EP}Fmr1EP3517 insertion.